Hereditary protein C deficiency.
Hereditary protein C deficiency, which is inherited as an autosomal-dominant trait, predisposes to venous thrombotic disease. Heterozygotes are at risk for superficial thrombophlebitis, deep venous thrombosis and/or pulmonary embolism, which may occur without apparent cause at a young age. Other manifestations are cerebral venous thrombosis and mesenteric vein thrombosis. In severe, often homozygous, protein C deficiency, a purpura fulminans syndrome may occur shortly after birth, resulting in death due to extensive thrombosis, if it is not adequately treated. The thrombotic manifestations in heterozygotes are effectively prevented by coumarin therapy. However, in the initial phase of oral anticoagulant therapy, the patients have an increased risk for the development of coumarin-induced haemorrhagic skin necrosis. The purpura fulminans syndrome can be treated with either replacement therapy or with coumarin therapy. Heparin appears to be ineffective in the prevention of both the purpura fulminans syndrome and the coumarin-induced skin necrosis.
D001778:Blood Coagulation Disorders / Q000150:complications / Q000175:diagnosis / Q000235:genetics*; D001779:Blood Coagulation Factors / Q000032:analysis / Q000235:genetics*; D002544:Cerebral Infarction / Q000209:etiology; D006023:Glycoproteins / Q000032:analysis / Q000235:genetics*; D006801:Humans; D011486:Protein C; D013923:Thromboembolism / Q000209:etiology*; D013927:Thrombosis / Q000209:etiology
D001779:Blood Coagulation Factors; D006023:Glycoproteins; D011486:Protein C